Partnering

THE BIO-GATE TO A HEALTHIER LIFE

AbGenomics actively pursues partnerships worldwide to develop our product candidates and technology platforms. We seek win-win opportunities with partners in our mission to develop best-in-class bio-therapeutics. AbGenomics seeks co-development collaboration and marketing partnerships as a better, healthier tomorrow is built by a global community.

Our Focus and Strategy

Fulfilling Unmet Medical Needs.

As a specialty biopharmaceutical company, AbGenomics is committed to the discovery and development of innovative monoclonal antibody products. Our specific set of niche products address significant unmet medical needs. To achieve this goal, we seek opportunities to co-develop our products with strategic partners around the globe. AbGenomics is open to regional, global, product-specific and platform-specific collaboration.
Collaboration

Bringing Out the Best in Each Other!

AbGenomics recognizes the value of collaboration both commercially and in the clinic. Thus, we seek the highest caliber of collaborators from a wide range of professional fields. AbGenomics builds close relationships with world-class industrial CROs/CMOs and academic institutions in order to collaborate on research and clinical projects. Our clinical trials have been performed by well-established clinical sites in renowned medical institutions throughout the U.S. AbGenomics invites global partners to join us in co-developing our products and technology.

We need to join hands with major foreign players as
their global distribution networks would help us expand”

-Ronghwa Lin, Ph.D. AbGenomics' CEO

Contact Us